These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8466716)

  • 1. Antihypertensive efficacy, safety, and tolerability of isradipine in hypertensive patients with diabetes.
    Parreira JM; Correia LG; Pereira E; Duarte RS; Pape E
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):104S-106S. PubMed ID: 8466716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of isradipine and nifedipine retard in hypertensive patients with type II diabetes mellitus.
    Gomis R; Vidal J; Novials A; Coves MJ
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):102S-103S. PubMed ID: 8466715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of isradipine in non-insulin-dependent diabetes mellitus (NIDDM) hypertensive patients.
    Ferrara LA; De Simone G; Iannuzzi R; Gaeta I; D'Orta G; Turco S; Guida L; Marotta T
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):459-60. PubMed ID: 8527356
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy, safety, and tolerability of isradipine in hypertension as used in general practice in a developing country (Pakistan).
    Samad A; Khan AH; Hashmi MS
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):54S-56S. PubMed ID: 8466727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
    Widimský J; Sirotiaková J
    Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.
    Nørgaard K; Jensen T; Christensen P; Feldt-Rasmussen B
    Blood Press; 1993 Dec; 2(4):301-8. PubMed ID: 8173700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of non-insulin-dependent diabetic hypertensive patients with Ca2+ channel blockers is associated with increased platelet sensitivity to insulin.
    Touyz RM; Schiffrin EL
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1214-21. PubMed ID: 8998256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus.
    Klauser R; Prager R; Gaube S; Gisinger C; Schnack C; Küenburg E; Schernthaner G
    Hypertension; 1991 Jan; 17(1):15-21. PubMed ID: 1824760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine, felodipine, and isradipine in the treatment of Chinese patients with mild-to-moderate hypertension.
    Cheung BM; Lau CP; Wu BZ
    Clin Ther; 1998; 20(6):1159-69. PubMed ID: 9916609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women.
    Perry HM; Hall WD; Benz JR; Bartels DW; Kostis JB; Townsend RR; Due DL; Peng A; Sirgo M
    Am J Med; 1994 Jan; 96(1):77-86. PubMed ID: 8304366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, tolerability and safety of isradipine (Lomir) in the treatment of mild to moderate Tanzanian hypertensives.
    Lwakatare JM; Maro EE; Mtulia IA
    East Afr Med J; 1992 Dec; 69(12):683-7. PubMed ID: 1298633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isradipine in prediabetic hypertensive subjects.
    Byington RP; Furberg CD; Craven TE; Pahor M; Sowers JR
    Diabetes Care; 1998 Dec; 21(12):2103-10. PubMed ID: 9839101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
    Burger KJ; Dehner R
    Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of assessment of natriuresis and diuresis in the course of isradipine treatment of hypertension in patients with hypertension and type II diabetes].
    Moiseev VS; Konurina IIu; Krasnobaeva GM; Ivleva AIa
    Klin Lab Diagn; 1995; (1):18-20. PubMed ID: 7757358
    [No Abstract]   [Full Text] [Related]  

  • 15. Hungarian Isradipine Study (HIS): long-term (3-year) effects on blood pressure and plasma lipids.
    Farsang C; Kapocsi J; Kiss I; Török E; Kerkovits G; Holló J; Jávor T
    Am J Hypertens; 1994 Jul; 7(7 Pt 2):56S-60S. PubMed ID: 7946181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension.
    Brogden RN; Sorkin EM
    Drugs; 1995 Apr; 49(4):618-49. PubMed ID: 7789292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring.
    Galderisi M; Petrocelli A; Garofalo M; Celentano A; Alfieri A; de Divitiis O
    J Int Med Res; 1995; 23(4):234-43. PubMed ID: 7589766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isradipine-SRO: antihypertensive efficacy, central and peripheral hemodynamic effects in patients with hypertensive disease].
    Podzolkov VI; Bartieva DM; Makolkin VI
    Kardiologiia; 2003; 43(6):33-8. PubMed ID: 12891309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose titration study of isradipine in Chinese patients with mild to moderate essential hypertension.
    Chen MF; Chen CC; Chen WJ; Wu CC; Liau CS; Lee YT
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):133-8. PubMed ID: 8485068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of left ventricular hypertrophy with isradipine in previously untreated hypertensive patients.
    Manolis AJ; Kolovou G; Handanis S; Athanasopoulos G; Antonopoulos S; Cokkinos DV
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):86S-88S. PubMed ID: 8466737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.